Youngsun Kim is Senior Director of the Multi-modality MSAT team at Samsung Biologics. He has an extensive background in the biotech industry with more than 20 years of industrial experience in process tech transfer, process development/characterization, process scale-up, facility design and manufacturing for product introductions as well as commercial projects. Prior to joining Samsung Biologics, Youngsun served as a manager for a few US-based biotech, including VaxInnate, Adello Biologics, and Kashiv Biosciences. He earned a Ph.D. in Chemical and Biochemical Engineering at Rutgers University in New Jersey, United States.